ArticleToxics2026
Associations of Serum Trace-Element Concentrations with Selected Blood Biomarkers: A Secondary Cross-Sectional Analysis of the SPES Cohort.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Trace elements have nutritional and toxicological roles relevant to lipid metabolism and inflammation. In a secondary cross-sectional study, we examined 19 serum elements and blood biomarkers in 4026 adults from the SPES community biomonitoring programme in Campania, Italy. Low-density lipoprotein cholesterol (LDL-C) and neutrophil-to-lymphocyte ratio (NLR) were co-primary outcomes; systemic immune-inflammation index (SII) was secondary. Adjusted models used multiple imputation and false-discovery-rate (FDR) correction. Selenium, copper and zinc showed positive LDL-C associations among directly quantified concentrations, whereas the mercury association depended on assay availability and quantification. Models with untransformed LDL-C estimated differences of approximately 1-4 mg/dL per element-specific interquartile increase in log concentration. Copper and zinc estimates were smaller in an exploratory joint model. For mercury, LDL-C was higher with quantifiable rather than below-quantification concentrations, but the gradient within the quantified range was uncertain. All four primary-model LDL-C associations met both outcome-specific and combined co-primary FDR thresholds; no primary linear NLR association did. Copper, cobalt, molybdenum and antimony were associated with higher SII after outcome-specific FDR correction, with less consistent results across sensitivity analyses. These modest LDL-C differences warrant prospective investigation; the cross-sectional associations do not establish causal or individual clinical effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.